Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01577693 · ClinicalTrials.gov registry record · Phase 1
Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Healthy Male Subjects
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 35
- Enrollment target
NCT01577693 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 35 participants.
The verdict
NCT01577693, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the bioavailability of 0.5mg dutasteride novel formulation compared to the currently marketed 0.5mg dutasteride soft gel capsule in fasted healthy male subjects.
Interventions
- DRUG dutasteride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2011-05-12 |
| Est. Completion | 2011-08-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01577693
The ClinicalTrials.gov registry entry for NCT01577693 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which dutasteride is the first listed.
NCT01577693 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01577693 about?
NCT01577693 is a clinical study titled "Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Healthy Male Subjects". The purpose of this study is to determine the bioavailability of 0.5mg dutasteride novel formulation compared to the currently marketed 0.5mg dutasteride soft gel capsule in fasted healthy male subjects.
What is the current status of trial NCT01577693?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 35 participants. The study started on 2011-05-12. Estimated completion is 2011-08-31.
What interventions are being tested in trial NCT01577693?
The interventions under investigation include: dutasteride (DRUG).
Who is sponsoring clinical trial NCT01577693?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.